Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CTCX

Carmell Corp

Dec 12 • 09:30AM ET

0.2254

Dollar change +0.0043
Percentage change 1.94	%

Consumer Defensive • Household & Personal Products • USA • NASD

Peers: SRDX MDXG AXGN RCEL OSUR VERO PAVM HSDT SENS

| Held by: VXF IWC VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.56	Insider Own	35.59%	Shs Outstand	20.91M	Perf Week	-30.75%
Market Cap	4.71M	Forward P/E	-	EPS next Y	-	Insider Trans	0.61%	Shs Float	13.47M	Perf Month	-19.21%
Income	-10.38M	PEG	-	EPS next Q	-	Inst Own	9.82%	Short Float	1.17%	Perf Quarter	-52.04%
Sales	3.73M	P/S	1.26	EPS this Y	-	Inst Trans	13.83%	Short Ratio	0.03	Perf Half Y	-88.73%
Book/sh	-0.07	P/B	-	EPS next Y	-	ROA	-8.68%	Short Interest	0.16M	Perf Year	-92.66%
Cash/sh	0.11	P/C	2.14	EPS next 5Y	-	ROE	-12.12%	52W Range	0.20 - 4.31	Perf YTD	-94.08%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-94.77%	Beta	0.29
Dividend TTM	-	Quick Ratio	0.69	Sales past 5Y	0.00%	Gross Margin	47.08%	52W Low	12.08%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	0.71	EPS Y/Y TTM	-4023.53%	Oper. Margin	-188.68%	RSI (14)	37.18	Volatility	15.20% 14.20%
Employees	10	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-278.42%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-647.77%	Payout	-	Rel Volume	0.75	Prev Close	0.22
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	4.85M	Price	0.23
SMA20	-17.72%	SMA50	-31.51%	SMA200	-83.50%	Trades		Volume	181,568	Change	1.94%

Sep-05-24 08:30AM	Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community (GlobeNewswire) -11.29%
Jul-29-24 08:30AM	Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index (GlobeNewswire) +13.00%
May-16-24 08:54AM	CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 04:30PM	Carmell Announces Successful Closing of $3.0 Million Private Placement (GlobeNewswire) -5.60%
Apr-04-24 08:30AM	Carmell Announces $3.0 Million Private Placement (GlobeNewswire) -9.72%
09:15AM	Loading…
Mar-27-24 09:15AM	Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction (GlobeNewswire) -11.03%
Mar-20-24 04:39PM	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary (GlobeNewswire) +11.84% +5.84%
Mar-18-24 03:16PM	Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field (GlobeNewswire)
Feb-26-24 08:30AM	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 (GlobeNewswire) +28.92%
Nov-16-23 08:30AM	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors (GlobeNewswire)
Sep-12-23 12:35PM	Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine (PR Newswire)
Sep-05-23 06:03PM	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics (GlobeNewswire) +17.60%
Aug-09-23 03:41PM	Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity (Business Wire)
Jul-27-23 07:00AM	Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (Business Wire) +46.00%

Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Upton Richard A	Director	Sep 13 '24	Buy	0.47	5,000	2,336	15,000	Sep 16 04:30 PM
Gregory Kathryn	Director	Sep 06 '24	Buy	0.51	1,260	643	22,500	Sep 10 04:30 PM
Sturgeon Patrick A	Director	Sep 06 '24	Buy	0.51	1,261	643	18,051	Sep 10 04:30 PM
Cassaday Bryan J.	Chief Financial Officer	Sep 10 '24	Buy	0.46	475	218	4,250	Sep 10 04:30 PM
Frisch Scott M.	Director	Sep 06 '24	Buy	0.51	1,009	515	7,598	Sep 10 04:30 PM
Spenlehauer Gilles	Director	Sep 06 '24	Buy	0.51	1,009	515	7,598	Sep 10 04:30 PM
Gregory Kathryn	Director	Aug 30 '24	Buy	0.57	109	62	21,240	Sep 04 06:26 PM
Frisch Scott M.	Director	Aug 30 '24	Buy	0.57	87	50	6,589	Sep 04 04:51 PM
Sturgeon Patrick A	Director	Aug 30 '24	Buy	0.57	109	62	16,790	Sep 04 04:39 PM
Spenlehauer Gilles	Director	Aug 30 '24	Buy	0.57	87	50	6,589	Sep 04 04:34 PM
Sturgeon Patrick A	Director	Aug 28 '24	Buy	0.56	970	543	16,029	Aug 30 04:30 PM
Sturgeon Patrick A	Director	Aug 29 '24	Buy	0.56	652	365	16,681	Aug 30 04:30 PM
Frisch Scott M.	Director	Aug 28 '24	Buy	0.56	599	335	5,980	Aug 30 04:30 PM
Frisch Scott M.	Director	Aug 29 '24	Buy	0.56	522	292	6,502	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 28 '24	Buy	0.56	1,084	607	20,479	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 29 '24	Buy	0.56	652	365	21,131	Aug 30 04:30 PM
Cassaday Bryan J.	Chief Financial Officer	Aug 29 '24	Buy	0.57	1,000	570	3,775	Aug 30 04:30 PM
Anderson David W	Director	Aug 28 '24	Buy	0.56	749	419	7,476	Aug 30 04:30 PM
Anderson David W	Director	Aug 29 '24	Buy	0.56	652	365	8,128	Aug 30 04:30 PM
Spenlehauer Gilles	Director	Aug 28 '24	Buy	0.56	599	335	5,980	Aug 30 04:30 PM
Spenlehauer Gilles	Director	Aug 29 '24	Buy	0.56	522	292	6,502	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 27 '24	Buy	0.71	2,413	1,713	19,395	Aug 29 05:19 PM
Sturgeon Patrick A	Director	Aug 27 '24	Buy	0.71	1,587	1,127	15,059	Aug 29 05:17 PM
Sturgeon Patrick A	Director	Aug 26 '24	Buy	0.72	1,587	1,143	13,472	Aug 26 07:59 PM
Sturgeon Patrick A	Director	Aug 23 '24	Buy	0.72	1,587	1,143	11,885	Aug 26 07:59 PM
Gregory Kathryn	Director	Aug 26 '24	Buy	0.72	2,413	1,737	16,981	Aug 26 07:58 PM
Gregory Kathryn	Director	Aug 23 '24	Buy	0.72	2,413	1,737	14,568	Aug 26 07:58 PM
Sturgeon Patrick A	Director	Dec 15 '23	Buy	0.72	1,587	1,143	10,298	Aug 23 05:25 PM
Sturgeon Patrick A	Director	Aug 21 '24	Buy	0.08	1,984	157	8,711	Aug 23 05:25 PM
Gregory Kathryn	Director	Aug 21 '24	Buy	0.79	3,016	2,389	9,743	Aug 23 05:08 PM
Gregory Kathryn	Director	Aug 22 '24	Buy	0.72	2,413	1,737	12,156	Aug 23 05:08 PM
Upton Richard A	Director	Aug 20 '24	Buy	0.89	3,600	3,218	10,000	Aug 21 05:57 PM
Upton Richard A	Director	Jun 12 '24	Buy	2.20	2,000	4,409	6,400	Jun 14 08:21 AM
Cassaday Bryan J.	Chief Financial Officer	Jun 10 '24	Buy	2.50	440	1,100	2,775	Jun 12 07:59 AM
Shukla Rajiv	Chairman and CEO	Jun 06 '24	Buy	2.63	2,100	5,527	72,103	Jun 10 09:03 AM
Shukla Rajiv	Chairman and CEO	May 30 '24	Buy	2.50	2,000	5,000	70,003	Jun 10 09:03 AM
Shukla Rajiv	Chairman and CEO	May 28 '24	Buy	2.57	20	51	68,003	Jun 10 09:03 AM
Cassaday Bryan J.	Chief Financial Officer	May 30 '24	Buy	2.55	365	931	2,335	May 31 05:25 PM
Cassaday Bryan J.	Chief Financial Officer	May 29 '24	Buy	2.60	30	78	1,970	May 31 05:25 PM
Shukla Rajiv	Chairman and CEO	May 23 '24	Buy	2.50	2,100	5,250	66,044	May 28 05:02 PM
Shukla Rajiv	Chairman and CEO	May 24 '24	Buy	2.57	1,939	4,991	67,983	May 28 05:02 PM
Shukla Rajiv	Chairman and CEO	May 22 '24	Buy	2.41	4,051	9,771	63,944	May 22 05:13 PM
Shukla Rajiv	Chairman and CEO	May 21 '24	Buy	2.39	1,515	3,616	59,893	May 22 05:13 PM
Shukla Rajiv	Chairman and CEO	May 20 '24	Buy	2.22	1,172	2,601	58,378	May 22 05:13 PM
Shukla Rajiv	Chairman and CEO	Apr 04 '24	Buy	2.88	8,680	24,998	57,206	May 22 05:10 PM
Cassaday Bryan J.	Chief Financial Officer	Dec 14 '23	Buy	3.50	440	1,540	1,940	Dec 19 05:00 PM
Spenlehauer Gilles	Director	Dec 15 '23	Buy	3.94	591	2,326	5,381	Dec 18 05:13 PM
Spenlehauer Gilles	Director	Dec 14 '23	Buy	3.61	313	1,131	4,790	Dec 18 05:13 PM
Frisch Scott M.	Director	Dec 15 '23	Buy	3.94	591	2,326	5,381	Dec 18 05:12 PM
Frisch Scott M.	Director	Dec 14 '23	Buy	3.61	313	1,131	4,790	Dec 18 05:12 PM
Sturgeon Patrick A	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:11 PM
Sturgeon Patrick A	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:11 PM
Gregory Kathryn	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:10 PM
Gregory Kathryn	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:10 PM
Anderson David W	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:10 PM
Anderson David W	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:10 PM
Upton Richard A	Director	Dec 13 '23	Buy	3.47	2,400	8,330	4,400	Dec 13 09:53 PM
Sturgeon Patrick A	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:48 PM
Frisch Scott M.	Director	Dec 13 '23	Buy	5.57	869	4,841	4,477	Dec 13 09:38 PM
Spenlehauer Gilles	Director	Dec 13 '23	Buy	5.57	869	4,841	4,477	Dec 13 09:37 PM
Gregory Kathryn	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:36 PM
Anderson David W	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CTCX

Carmell Corp

Upgrade your FINVIZ experience